At noon on October 16, Yipinhong announced that Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for paramivir injections approved and issued by the State Drug Administration. Paramivir injections are used to treat influenza A or B. Currently, peramivir injections have been included in the national medical insurance category B catalogue. The company uses 3 types of chemicals for registration, which is deemed to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.